Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
AnPac Bio-Medical Science Co. Ltd. ADR Class A
ANPC
$
5.74
2.5%
Wed September 23rd, 2020
12:15
Press Releases
Tiger Asia Intelligence reiterates a Buy rating on AnPac Bio, Ltd (NASDAQ:ANPC)
PR Newswire
Thu September 10th, 2020
16:08
Earnings
Analysis
AnPac Bio-Medical Science Co., Ltd (ANPC) CEO Chris Yu on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha
Tue September 8th, 2020
08:46
Analysis
AbbVie I-Mab Cancer Deal, And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha
Sat July 25th, 2020
12:52
IPO
Analysis
U.S. IPO Week Ahead: Tax Software Leads A Diverse 7-IPO Week
Seeking Alpha
12:26
Analysis
Stocks To Watch: Big Focus On Big Tech
Seeking Alpha
Wed June 10th, 2020
20:20
Press Releases
Tiger Asia Intelligence reiterate Buy rating on AnPac Bio, Ltd (NASDAQ:ANPC)
PR Newswire
